|
Adam Rosenblatt, M.D.
Statement of Interest
Program Affiliations
Assistant Professor: Department of Psychiatry
Principal Investigator, Clinical Core, Baltimore Huntington's
Disease Center
Principal Investigator, PHAROS
Principal Investigator, A multicentre, multinational, double blind, randomised,
parallel group, placebo controlled trial of ethyl eicosapentaenoate in patients
with Huntington's disease.
Investigator, Dementias and Psychiatric Disorders in Assisted Living
Biographical Sketch
|
 |
 |
|